{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:49:28Z","timestamp":1773924568572,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008799","name":"Stiftung f\u00fcr Pathobiochemie und Molekulare Diagnostik","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008799","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.prostaglandins.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T06:16:48Z","timestamp":1498112208000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol"],"prefix":"10.1016","volume":"131","author":[{"given":"Sabrina","family":"Krautbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","article-title":"Liver cirrhosis","volume":"25","author":"Pinzani","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0010","doi-asserted-by":"crossref","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","article-title":"Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/BF01537534","article-title":"Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis","volume":"61","author":"Breier","year":"1983","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2011.10.037","article-title":"Quantification of bioactive sphingo- and glycerophospholipid species by electrospray ionization tandem mass spectrometry in blood","volume":"883\u2013884","author":"Liebisch","year":"2012","journal-title":"J. Chromatogr. B Analy. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.bbalip.2011.06.016","article-title":"Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry","volume":"1811","author":"Scherer","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0035","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/hep.27587","article-title":"Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection","volume":"61","author":"Grammatikos","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0040","doi-asserted-by":"crossref","first-page":"e0138130","DOI":"10.1371\/journal.pone.0138130","article-title":"Serum sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis","volume":"10","author":"Grammatikos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prostaglandins.2016.06.001","article-title":"Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis","volume":"124","author":"Krautbauer","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0050","doi-asserted-by":"crossref","first-page":"e0130346","DOI":"10.1371\/journal.pone.0130346","article-title":"Circulating lipids are associated with alcoholic liver cirrhosis and represent potential biomarkers for risk assessment","volume":"10","author":"Meikle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2015.01.020","article-title":"Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection","volume":"33","author":"Zheng","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"ABBV Trends Endocrinol Metab"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/oby.2009.326","article-title":"Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum","volume":"18","author":"Kotronen","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0070","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbalip.2014.04.007","article-title":"Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease","volume":"1841","author":"Grammatikos","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0075","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.biocel.2013.03.012","article-title":"The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS","volume":"45","author":"Hartmann","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1194\/jlr.M042002","article-title":"Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain","volume":"55","author":"Pinto","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0085","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bbalip.2016.08.016","article-title":"Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: a beneficial role for very long-chain sphingolipid species","volume":"1861","author":"Montgomery","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3892\/mmr.2015.3361","article-title":"Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0095","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yexmp.2015.01.010","article-title":"Reduced serum chemerin in patients with more severe liver cirrhosis","volume":"98","author":"Eisinger","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbalip.2005.12.007","article-title":"High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI\u2013MS\/MS)","volume":"1761","author":"Liebisch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0120","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0022-2275(20)33398-8","article-title":"Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI\u2013MS\/MS)","volume":"40","author":"Liebisch","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0885-4505(88)90132-6","article-title":"Serum apoproteins A and B and the lecithin: cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients","volume":"40","author":"Nayak","year":"1988","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0026-0495(93)90166-L","article-title":"Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease","volume":"42","author":"Tahara","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0135","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbalip.2012.02.007","article-title":"Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity","volume":"1821","author":"Subbaiah","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"51","key":"10.1016\/j.prostaglandins.2017.06.004_bib0140","article-title":"Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients","volume":"16","author":"Arain","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3164\/jcbn.12-79","article-title":"Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis\u2014a pilot study","volume":"53","author":"Ristic-Medic","year":"2013","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0150","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","article-title":"Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child\u2019s status","volume":"51","author":"Wadhawan","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0155","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000339206","article-title":"Lipid serum profile in patients with viral liver cirrhosis","volume":"21","author":"Vere","year":"2012","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1665-2681(19)31342-0","article-title":"Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients","volume":"12","author":"Janicko","year":"2013","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0170","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3748\/wjg.v16.i11.1397","article-title":"Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis","volume":"16","author":"Jiang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0016-5085(83)90431-6","article-title":"In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease","volume":"85","author":"Monroe","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gines","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0185","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3748\/wjg.v21.i10.3020","article-title":"Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis","volume":"21","author":"Kalafateli","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2017.06.004_bib0190","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/gut.2010.234542","article-title":"Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS","volume":"60","author":"Holland-Fischer","year":"2011","journal-title":"Gut"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T23:10:29Z","timestamp":1659136229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":38,"alternative-id":["S1098882317300503"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.06.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}